Kenya Expands One Health Antimicrobial Resistance Surveillance

A narrative overview of Kenya’s Fleming Fund-supported antimicrobial resistance (AMR) surveillance examined programmatic learning since 2018, using national and global surveillance reports, Quadripartite indicators, qualitative evidence, and program documentation. It assessed changes in governance, implementation, reporting, and policy across One Health sectors.

The authors report that surveillance expanded from 2 human health sites in 2018 to 30 sites across human, animal, and environmental health by 2025. National reports increasingly integrated AMR, antimicrobial consumption, and antimicrobial use data, while routine reporting to global platforms matured. Dashboards, reports, and policy briefs were used to inform stewardship, infection prevention and control, regulatory action, and policy decisions. WHO Joint External Evaluation scores for surveillance and multisectoral coordination reportedly rose from limited to demonstrated capacity.

The overview concludes that progress has relied on government-led governance, technical systems, and coordinated partner support. Predictable financing and routine use of surveillance data remain challenges. This is a programmatic narrative overview rather than a controlled evaluation, so the reported changes do not establish that the Fleming Fund alone caused improvements or quantify effects on AMR outcomes.